Under dual PI3Kδ/γ inhibition, a decrease of macrophage-attracting chemokines (i.e., CSF-1, CCL5, TARC/CCL17) is seen and leads to a significant reduction of F4/80+ TAMs in Hodgkin lymphoma xenografts. Here, CCL17 is linked to Hodgkins lymphoma.